Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by LongTermWinneron Jul 31, 2020 9:43pm
219 Views
Post# 31352821

RE:RE:We are Professionals not Cowboys says Barry Fishman at AGM !

RE:RE:We are Professionals not Cowboys says Barry Fishman at AGM !I'd read more into the timing if the conference call wasn't on Monday. If they were looking to bury bad earnings they would do the conference call after hours on Friday as well. They had to release earnings on or before August 15th no matter what, so it seems like they chose the last possible day to release the numbers while setting up a conference call to start the following week, implying a high possibility of looking for a positive catalyst to spark a strong week.

But who knows, might have zero implication on performance whatsoever. This isn't a large cap company strategizing for volume and attention. More likely this is another quarter of steady growth that is one step closer to profitability. Big positive catalyst will be EU-GMP certification, and of course there's always the threat of utilizing the shelf prospectus, but I would be very surprised if they tap into it anywhere near these valuations, if at all.

Time will tell, but I support has been immensely strong and I think we're looking at two strong weeks of continued momentum. Good luck.
<< Previous
Bullboard Posts
Next >>